発症時にループス抗凝固因子を認めた急性巨核芽球性白血病 症例報告と造血器悪性腫瘍に合併する抗リン脂質抗体の文献的検討

症例は, 急性巨核芽球性白血病と診断された1歳10カ月の男児.発症時にプロトロンビン時間 (prothrombin time, PT) と活性化部分トロンボプラスチン時間 (activated partial thromboplastin time, APTT) の延長, 抗doublestrandDNA抗体, biologically false positive serologic tests for syphilis (BFP-STS) を認め, ループス抗凝固因子 (lupus anticoagulant, LA) の存在が証明された.化学療法開始後1週間でPTとAPTTは改善傾向を示...

Full description

Saved in:
Bibliographic Details
Published in日本小児血液学会雑誌 Vol. 13; no. 5; pp. 365 - 370
Main Authors 中村, 誠, 滝, 正志, 合井, 久美子, 柄木田, 直子, 中澤, 眞平, 宮本, 直彦, 杉田, 完爾, 飯島, 純
Format Journal Article
LanguageJapanese
Published 特定非営利活動法人 日本小児血液・がん学会 31.10.1999
Subjects
Online AccessGet full text
ISSN0913-8706
1884-4723
DOI10.11412/jjph1987.13.365

Cover

Abstract 症例は, 急性巨核芽球性白血病と診断された1歳10カ月の男児.発症時にプロトロンビン時間 (prothrombin time, PT) と活性化部分トロンボプラスチン時間 (activated partial thromboplastin time, APTT) の延長, 抗doublestrandDNA抗体, biologically false positive serologic tests for syphilis (BFP-STS) を認め, ループス抗凝固因子 (lupus anticoagulant, LA) の存在が証明された.化学療法開始後1週間でPTとAPTTは改善傾向を示し, BFP-STSは陰性化した.さらに, 完全寛解を確認した化学療法開始後41日の時点で, PTとAPTTは正常化しLAは陰性となった.全経過を通じて血栓症は認められなかった.造血器悪性腫瘍では, 発症時に抗リン脂質抗体 (antiphospholipid antibody, APA) が出現し, LA陽性例の一部では血栓症の原因となることがある.しかし, 本症例や文献的には, 造血器悪性腫瘍に合併したAPAは残存腫瘍の減少に伴い速やかに消失するため, 腫瘍が化学療法に抵抗性でない限り, 血栓症の予防は必要がないと考えられる.
AbstractList 症例は, 急性巨核芽球性白血病と診断された1歳10カ月の男児.発症時にプロトロンビン時間 (prothrombin time, PT) と活性化部分トロンボプラスチン時間 (activated partial thromboplastin time, APTT) の延長, 抗doublestrandDNA抗体, biologically false positive serologic tests for syphilis (BFP-STS) を認め, ループス抗凝固因子 (lupus anticoagulant, LA) の存在が証明された.化学療法開始後1週間でPTとAPTTは改善傾向を示し, BFP-STSは陰性化した.さらに, 完全寛解を確認した化学療法開始後41日の時点で, PTとAPTTは正常化しLAは陰性となった.全経過を通じて血栓症は認められなかった.造血器悪性腫瘍では, 発症時に抗リン脂質抗体 (antiphospholipid antibody, APA) が出現し, LA陽性例の一部では血栓症の原因となることがある.しかし, 本症例や文献的には, 造血器悪性腫瘍に合併したAPAは残存腫瘍の減少に伴い速やかに消失するため, 腫瘍が化学療法に抵抗性でない限り, 血栓症の予防は必要がないと考えられる.
Author 滝, 正志
杉田, 完爾
中村, 誠
合井, 久美子
中澤, 眞平
飯島, 純
柄木田, 直子
宮本, 直彦
Author_FL GOI Kumiko
NAKAMURA Makoto
SUGITA Kanji
KARAKIDA Naoko
MIYAMOTO Naohiko
NAKAZAWA Shinpei
TAKI Masashi
IIJIMA Kiyomu
Author_FL_xml – sequence: 1
  fullname: NAKAMURA Makoto
– sequence: 2
  fullname: SUGITA Kanji
– sequence: 3
  fullname: IIJIMA Kiyomu
– sequence: 4
  fullname: GOI Kumiko
– sequence: 5
  fullname: MIYAMOTO Naohiko
– sequence: 6
  fullname: KARAKIDA Naoko
– sequence: 7
  fullname: TAKI Masashi
– sequence: 8
  fullname: NAKAZAWA Shinpei
Author_xml – sequence: 1
  fullname: 中村, 誠
  organization: 山梨医科大学小児科
– sequence: 1
  fullname: 滝, 正志
  organization: 聖マリアンナ医科大学小児科
– sequence: 1
  fullname: 合井, 久美子
  organization: 山梨医科大学小児科
– sequence: 1
  fullname: 柄木田, 直子
  organization: 山梨医科大学小児科
– sequence: 1
  fullname: 中澤, 眞平
  organization: 山梨医科大学小児科
– sequence: 1
  fullname: 宮本, 直彦
  organization: 山梨医科大学小児科
– sequence: 1
  fullname: 杉田, 完爾
  organization: 山梨医科大学小児科
– sequence: 1
  fullname: 飯島, 純
  organization: 山梨医科大学小児科
BackLink https://cir.nii.ac.jp/crid/1572261550009291520$$DView record in CiNii
BookMark eNo9UE1Lw0AUXKSCtfbuD_Caum8322yOUj-hIIKewybZ2IRaS9KLtzZFCgWheAmliPUgiuJZLfbXhCT9GUaqwmMejzczDLOOCq3LlkRoE3AFQAWy7XntBuhcqwCt0CpbQUXgXFVUjdACKmIdqMI1XF1D5SBwTYwZ5xirWhGdZONZFg3ScRj3XuN-Pl9xP4rDz3QYJYO7ZDJLJtPkbRSHt4uXmzjsxb37tPuYdp-S9-d0-rEYzrNRPz-z8Xzx0M2i6w206ohmIMu_u4TO9vdOa4dK_fjgqLZTV7w8MlaI4FQ4XDeFFCaTzKTMti2bmphjUCWnFlimEAIs29EElVI6RAXJGWU0lzm0hLaWvi3XNSz3B4FphFSBMYyxTnRgBOe03SXNCzriXBpt370Q_pUh_I5rNaXx15wB1GBLyAv8f1sN4RueoN_o4oZw
ContentType Journal Article
Copyright (社)日本複写権センター
Copyright_xml – notice: (社)日本複写権センター
DBID RYH
DOI 10.11412/jjph1987.13.365
DatabaseName CiNii Complete
DatabaseTitleList
DeliveryMethod fulltext_linktorsrc
DocumentTitleAlternate Lupus Anticoagulant Revealed at the Onset of Acute Megakaryoblastic Leukemia A Case Report and Analysis of Literature on Antiphospholipid Antibodies Associated with Hematological Malignancies
DocumentTitle_FL Lupus Anticoagulant Revealed at the Onset of Acute Megakaryoblastic Leukemia A Case Report and Analysis of Literature on Antiphospholipid Antibodies Associated with Hematological Malignancies
EISSN 1884-4723
EndPage 370
ExternalDocumentID 10012251964
article_jjph1987_13_5_13_5_365_article_char_ja
GroupedDBID ALMA_UNASSIGNED_HOLDINGS
JSF
KQ8
RJT
RYH
ID FETCH-LOGICAL-j1140-2a83af89baeab5e5b35ddcd3b08014e83c1cbaaa1cdf7a3eeef241e85353f89f3
ISSN 0913-8706
IngestDate Thu Jun 26 22:16:03 EDT 2025
Wed Sep 03 06:30:02 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed false
IsScholarly true
Issue 5
Language Japanese
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-j1140-2a83af89baeab5e5b35ddcd3b08014e83c1cbaaa1cdf7a3eeef241e85353f89f3
OpenAccessLink https://www.jstage.jst.go.jp/article/jjph1987/13/5/13_5_365/_article/-char/ja
PageCount 6
ParticipantIDs nii_cinii_1572261550009291520
jstage_primary_article_jjph1987_13_5_13_5_365_article_char_ja
PublicationCentury 1900
PublicationDate 1999/10/31
1999-10-31
PublicationDateYYYYMMDD 1999-10-31
PublicationDate_xml – month: 10
  year: 1999
  text: 1999/10/31
  day: 31
PublicationDecade 1990
PublicationTitle 日本小児血液学会雑誌
PublicationTitleAlternate 日小血会誌
PublicationYear 1999
Publisher 特定非営利活動法人 日本小児血液・がん学会
Publisher_xml – name: 特定非営利活動法人 日本小児血液・がん学会
References 18) 鏑木淳一, 池田康夫 : 抗リン脂質抗体症候群とその対策.臨床血液36 : 320-324, 1995
1) 中澤眞平, 杉田完爾 : 小児急性巨核芽球性白血病の診断と臨床像.小児科診療51 : 229-234, 1988
10) McNeil HP, Chesterman CN, Krilis SA : Anticardiolipin antibodies and lupus anticoagulants comprise separate antibody subgroups with different phospholipid binding characteristics. Br J Haematol 73 : 506-513, 1989
8) Keung Y, Cobos E, Meyerrose G, et al : Progressive thrombosis after treatment of diffuse large cell nonHodgkin's lymphoma and concomitant lupus anticoagulant. Leuk & Lymphoma 20 : 341-345, 1996
15) Bevers EM, Galli M, Barbui T, et al : Lupus anticoagulant IgG's (LA) are not directed to phospholipids only, but to a complex of lipid-bound human prothrombin. Thromb Haemostas 66 : 629-632, 1991
5) Ciaudo M, Horellou MH, Audouin J, et al : Lupus anticoagulant associated with primary malignant lymphoma of the spleen : A report of four patients. Am J Hematol 38 : 271-276, 1991
9) Harris EN : Annotation : Antiphospholipid antibodies. Br J Haematol 74 : 1-9, 1990
2) Hunt JE, McNeil HP, Morgan GJ, et al : A phospholipid-beta-2 glycoprotein I complex is an antigen for anticardiolipin antibodies occurring in autoimmune disease but not with infection. Lupus 1 : 75-81, 1992
3) 滝正志 : 抗リン脂質抗体症候群.小児内科27 : 875-879, 1995
19) 小池隆夫 : 抗リン脂質抗体症候群の診断と治療.日内会誌87 : 466-469, 1998
14) Galli M, Comfurius P, Maassen C, et al : Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor. Lancet 335 : 1544-1547, 1990
7) Schiff DE, Ortega JA : Chorea, eosinophilia, and lupus anticoagulant associated with acute lymphoblastic leukemia. Pediatr Neurol 8 : 466-468, 1992
11) Oosting JD, Derksen RHWM, Bobbink IWG, et al : Antiphospholipid antibodies directed against a combination of phospholipids with prothrombin, protein C, or protein S : An explanation for their pathogenic mechanism? Blood 81 : 2618-2625, 1993
4) Stasi R, Stipa E, Masi M, et al : Antiphospholipid antibodies : Prevalence, clinical significance and correlation to cytokine levels in acute myeloid leukemia and non-Hodgkin's lymphoma. Thromb Haemostas 70 : 568-572, 1993
12) Roubey RAS : Autoantibodies to phospholipidbinding plasma proteins : A new view of lupus anticoagulants and other “antiphospholipid” autoantibodies. Blood 84 : 2854-2867, 1994
16) Bick RL : Antiphospholipid thombosis syndromes : Etiology, pathophysiology, diagnosis and management. Int J Hematol 65 : 193-213, 1997
17) Kim HD, Boggs DR : A syndrome resembling idiopathic thrombocytopenic purpura in 10 patients with diverse forms of cancer. Am J Med 67 : 371-377, 1979
6) Audouin J, Diebold J, Schvarts H, et al : Malignant lymphoplasmacytic lymphoma with prominent splenomegaly (primary lymphoma of the spleen). J Pathol 155 : 17-33, 1988
13) McNeil HP, Simpson RJ, Chesterman C, et al : Antiphospholipid antibodies are directed against a complex antigen that includes a lip.id-binding inhibitor of coagulation : β2-glycoprotein I (apolipoprotein H). Proc Natl Acad Sci USA 87 : 4120-4124, 1990
References_xml – reference: 9) Harris EN : Annotation : Antiphospholipid antibodies. Br J Haematol 74 : 1-9, 1990
– reference: 12) Roubey RAS : Autoantibodies to phospholipidbinding plasma proteins : A new view of lupus anticoagulants and other “antiphospholipid” autoantibodies. Blood 84 : 2854-2867, 1994
– reference: 17) Kim HD, Boggs DR : A syndrome resembling idiopathic thrombocytopenic purpura in 10 patients with diverse forms of cancer. Am J Med 67 : 371-377, 1979
– reference: 5) Ciaudo M, Horellou MH, Audouin J, et al : Lupus anticoagulant associated with primary malignant lymphoma of the spleen : A report of four patients. Am J Hematol 38 : 271-276, 1991
– reference: 8) Keung Y, Cobos E, Meyerrose G, et al : Progressive thrombosis after treatment of diffuse large cell nonHodgkin's lymphoma and concomitant lupus anticoagulant. Leuk & Lymphoma 20 : 341-345, 1996
– reference: 3) 滝正志 : 抗リン脂質抗体症候群.小児内科27 : 875-879, 1995
– reference: 19) 小池隆夫 : 抗リン脂質抗体症候群の診断と治療.日内会誌87 : 466-469, 1998
– reference: 10) McNeil HP, Chesterman CN, Krilis SA : Anticardiolipin antibodies and lupus anticoagulants comprise separate antibody subgroups with different phospholipid binding characteristics. Br J Haematol 73 : 506-513, 1989
– reference: 6) Audouin J, Diebold J, Schvarts H, et al : Malignant lymphoplasmacytic lymphoma with prominent splenomegaly (primary lymphoma of the spleen). J Pathol 155 : 17-33, 1988
– reference: 11) Oosting JD, Derksen RHWM, Bobbink IWG, et al : Antiphospholipid antibodies directed against a combination of phospholipids with prothrombin, protein C, or protein S : An explanation for their pathogenic mechanism? Blood 81 : 2618-2625, 1993
– reference: 2) Hunt JE, McNeil HP, Morgan GJ, et al : A phospholipid-beta-2 glycoprotein I complex is an antigen for anticardiolipin antibodies occurring in autoimmune disease but not with infection. Lupus 1 : 75-81, 1992
– reference: 15) Bevers EM, Galli M, Barbui T, et al : Lupus anticoagulant IgG's (LA) are not directed to phospholipids only, but to a complex of lipid-bound human prothrombin. Thromb Haemostas 66 : 629-632, 1991
– reference: 7) Schiff DE, Ortega JA : Chorea, eosinophilia, and lupus anticoagulant associated with acute lymphoblastic leukemia. Pediatr Neurol 8 : 466-468, 1992
– reference: 16) Bick RL : Antiphospholipid thombosis syndromes : Etiology, pathophysiology, diagnosis and management. Int J Hematol 65 : 193-213, 1997
– reference: 18) 鏑木淳一, 池田康夫 : 抗リン脂質抗体症候群とその対策.臨床血液36 : 320-324, 1995
– reference: 1) 中澤眞平, 杉田完爾 : 小児急性巨核芽球性白血病の診断と臨床像.小児科診療51 : 229-234, 1988
– reference: 14) Galli M, Comfurius P, Maassen C, et al : Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor. Lancet 335 : 1544-1547, 1990
– reference: 13) McNeil HP, Simpson RJ, Chesterman C, et al : Antiphospholipid antibodies are directed against a complex antigen that includes a lip.id-binding inhibitor of coagulation : β2-glycoprotein I (apolipoprotein H). Proc Natl Acad Sci USA 87 : 4120-4124, 1990
– reference: 4) Stasi R, Stipa E, Masi M, et al : Antiphospholipid antibodies : Prevalence, clinical significance and correlation to cytokine levels in acute myeloid leukemia and non-Hodgkin's lymphoma. Thromb Haemostas 70 : 568-572, 1993
SSID ssib005880047
ssj0003236711
ssib053390765
ssib002003923
ssib058493933
Score 1.4978317
Snippet 症例は, 急性巨核芽球性白血病と診断された1歳10カ月の男児.発症時にプロトロンビン時間 (prothrombin time, PT) と活性化部分トロンボプラスチン時間 (activated partial thromboplastin time, APTT) の延長, 抗doublestrandDNA抗体,...
SourceID nii
jstage
SourceType Publisher
StartPage 365
SubjectTerms acute megakaryoblastic leukemia
antiphospholipid antibody
Down syndrome
hematological malignancy
lupus anticoagulant
Subtitle 症例報告と造血器悪性腫瘍に合併する抗リン脂質抗体の文献的検討
Title 発症時にループス抗凝固因子を認めた急性巨核芽球性白血病
URI https://www.jstage.jst.go.jp/article/jjph1987/13/5/13_5_365/_article/-char/ja
https://cir.nii.ac.jp/crid/1572261550009291520
Volume 13
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX 日本小児血液学会雑誌, 1999/10/31, Vol.13(5), pp.365-370
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpR1Na9RANNR68SKKilUrPTjHrUkm2Zk5eEh2sxRFodBCbyGf2D3UUtqLp3aLFCpC8bKUItaDKIpntdhfE3a3P8P3Xj42tR5shRDevn3z3rz3ZjLvTWYmmvYgTEIRmqYBPU1YDSuNRSPkegypSmqkXMZmRIckPX3WnFu0Hi_ZSxOTr2urljbWw9no5V_3lVzEq4ADv-Iu2XN4tmIKCIDBv3AHD8P9n3zMPMGUYq5DgGCQ2HtNxEiTeRyCROa4BPAx4LYKAOgRMJmrsJR0CGMjE9VGQLnEmQBHR8BpM6UXpRSIkMxxmGwXGBCXC1UdYqgzxy4B4uwK5kjEADdXYnEQ6rap8jpWaUyc69UmEQYiCwXtejBNyopCimoxp0VSgFWHFLGpthWHJnPhMgtFnCbzLLSGAh0V6qiMUqNq5phIJJKjhDaSQJMsyBx9TAaMXSSgf5vEn1NlOkyJMRnVSEpiC_a2c3oLXQC1BR1dj0mvMnWdPxhVWqWikuxhoa7EQZCzrNMF42Jzo6oNgtj7kFwqcjuQe6UBoBxJVmQntB9oSU0DGIN2iHGxzojhBJAW2EY4Gji38UUckjdMt2g-slU2MX7WV_WpZYM38P15HmPkA6uU8CgQ-d7yauTltSeMXRtGef79kCIi4_mnZc4O9paBpwd3u6vPceps1uCzVcFTR6gXHdQvKX2D-3Z-gwJ--Tfuc_S7kGxdNoWgNR9P5mu5OG5jr8XSNox8tVfWkDYpXYyXDEBgr7gqcikMCzmelUjfA6_sUy6bAD0e_qEFBMRdSA_x3I9LK8vLtZh34Zp2tUhWZ5y85te1iW5wQ5sf7R-N-jvD_V629TXbhutXtt3Pej-Hu_3BzrvBwdHg4HDwbS_rvT358ibrbWVb74ebH4ebnwbfPw8Pf5zsHo_2tuHnaP_45MPmqP_qprbY8RZac43iwyyNroHLwc1A8iCVKgySILQTO-R2HEcxD3U8iyqRPDKiMAgCI4pTEfAkSVJIFBLIDGwOxVJ-S5tcebGS3NZmgijgkDM1eZxInIwJzDQyTSkSyGSCSE-mtEe5HfzV_PQd_3zOnNKmwXx-tIx3wxaQbeKkDB41pyB10e_8J_-72pVxR76nTa6vbSTTkKash_ep-fwGri32uQ
linkProvider Colorado Alliance of Research Libraries
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=%E7%99%BA%E7%97%87%E6%99%82%E3%81%AB%E3%83%AB%E3%83%BC%E3%83%97%E3%82%B9%E6%8A%97%E5%87%9D%E5%9B%BA%E5%9B%A0%E5%AD%90%E3%82%92%E8%AA%8D%E3%82%81%E3%81%9F%E6%80%A5%E6%80%A7%E5%B7%A8%E6%A0%B8%E8%8A%BD%E7%90%83%E6%80%A7%E7%99%BD%E8%A1%80%E7%97%85&rft.jtitle=%E6%97%A5%E6%9C%AC%E5%B0%8F%E5%85%90%E8%A1%80%E6%B6%B2%E5%AD%A6%E4%BC%9A%E9%9B%91%E8%AA%8C&rft.au=%E4%B8%AD%E6%9D%91%2C+%E8%AA%A0&rft.au=%E6%BB%9D%2C+%E6%AD%A3%E5%BF%97&rft.au=%E5%90%88%E4%BA%95%2C+%E4%B9%85%E7%BE%8E%E5%AD%90&rft.au=%E6%9F%84%E6%9C%A8%E7%94%B0%2C+%E7%9B%B4%E5%AD%90&rft.date=1999-10-31&rft.pub=%E7%89%B9%E5%AE%9A%E9%9D%9E%E5%96%B6%E5%88%A9%E6%B4%BB%E5%8B%95%E6%B3%95%E4%BA%BA%E3%80%80%E6%97%A5%E6%9C%AC%E5%B0%8F%E5%85%90%E8%A1%80%E6%B6%B2%E3%83%BB%E3%81%8C%E3%82%93%E5%AD%A6%E4%BC%9A&rft.issn=0913-8706&rft.eissn=1884-4723&rft.volume=13&rft.issue=5&rft.spage=365&rft.epage=370&rft_id=info:doi/10.11412%2Fjjph1987.13.365&rft.externalDocID=article_jjph1987_13_5_13_5_365_article_char_ja
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0913-8706&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0913-8706&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0913-8706&client=summon